- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 7 - The Complexities of Pathway Development
Dr Sonnad inquired how replacing brand drugs with generic equivalents can affect pathway adherence. She also asked panelist to discuss the differences between early-stage and late-stage disease regimens, as well as the degree of flexibility there is in regimen design.
Dr Sonnad inquired how replacing brand drugs with generic equivalents can affect pathway adherence. She also asked panelists to discuss the differences between early-stage and late-stage disease regimens, as well as the degree of flexibility there is in regimen design.
Dr Nabhan said providers’ participation in pathway development is essential. They are likely to offer a variety of critical contributions and recommendations, including the ability to recognize the nuances between early-stage and late-stage disease states.
Dr Yu said that documentation is not only key to regimen flexibility, but to monitor pathway toxicity. Developing regimens can also vary, more greatly for late-stage disease than it does for early-stage disease.
Dr Tischler said this disease state variation also means that regimens can be flexible. As a disease becomes more complex, however, it may be difficult to offer generic medications.
Dr Nabhan said pathways may need to adapt to newer medications, but there needs to be data to support their effectiveness so that they can be be included in a regimen.
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
